Literature DB >> 11599738

Reactivity of dog sera to whole-cell or recombinant antigens of Borrelia burgdorferi by ELISA and immunoblot analysis.

Louis A Magnarelli, Steven A Levy1, Jacob W Ijdo1, Caiyun Wu1, Steven J Padula1, Erol Fikrig1.   

Abstract

Enzyme-linked immunosorbent assays (ELISAs) with separate preparations of 10 purified recombinant antigens of Borrelia burgdorferi sensu stricto were used to test sera from 36 dogs not vaccinated with whole cells of this agent and from five dogs vaccinated with whole-cell B. burgdorferi bacteria. All dogs lived in tick-infested areas of Connecticut and south-eastern New York state, USA. The non-vaccinated dogs had limb or joint disorder, lameness and fever during the period 1984-1991 and had antibodies to B. burgdorferi, as determined by a polyvalent ELISA with whole-cell antigen. In re-analyses of sera for total immunoglobulins in ELISAs with recombinant antigens, reactions were most frequently recorded when outer-surface protein (Osp) F, protein (p)35, p37, p39 and p-41G (a flagellin component) were tested separately. Western immunoblots of a subset of 16 sera, positive by ELISA with whole-cell antigen and representing a range of antibody titres (640-40960), verified immune responses to these or other lysed whole-cell antigens. Sera from vaccinated dogs contained antibodies to OspA, OspB, p22, p37 and p41-G. Therefore, serological reactions to OspF, p35 and p39 were the most important indicators of natural exposure to B. burgdorferi. Serum reactivities to these recombinant antigens in ELISAs can be used to help identify possible natural infections of canine borreliosis in dogs not vaccinated with whole-cell B. burgdorferi and to provide information on the geographic distribution of this bacterium.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11599738     DOI: 10.1099/0022-1317-50-10-889

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

1.  Serum antibodies to whole-cell and recombinant antigens of Borrelia burgdorferi in cottontail rabbits.

Authors:  Louis A Magnarelli; Steven J Norris; Erol Fikrig
Journal:  J Wildl Dis       Date:  2012-01       Impact factor: 1.535

2.  Expression of the bmpB gene of Borrelia burgdorferi is modulated by two distinct transcription termination events.

Authors:  Ramesh Ramamoorthy; Natalie A McClain; Aarti Gautam; Dorothy Scholl-Meeker
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

3.  Dynamic longitudinal antibody responses during Borrelia burgdorferi infection and antibiotic treatment of rhesus macaques.

Authors:  Monica E Embers; Nicole R Hasenkampf; Mary B Jacobs; Mario T Philipp
Journal:  Clin Vaccine Immunol       Date:  2012-06-20

4.  Antibodies to Borrelia burgdorferi OspA, OspC, OspF, and C6 antigens as markers for early and late infection in dogs.

Authors:  Bettina Wagner; Heather Freer; Alicia Rollins; David Garcia-Tapia; Hollis N Erb; Christopher Earnhart; Richard Marconi; Patrick Meeus
Journal:  Clin Vaccine Immunol       Date:  2012-02-15

5.  A comparison of serologic tests for the detection of serum antibodies to whole-cell and recombinant Borrelia burgdorferi antigens in cattle.

Authors:  Louis A Magnarelli; Sandra L Bushmich; Bruce A Sherman; Erol Fikrig
Journal:  Can Vet J       Date:  2004-08       Impact factor: 1.008

6.  Diversity of antibody responses to Borrelia burgdorferi in experimentally infected beagle dogs.

Authors:  Elisabeth Baum; Deborah A Grosenbaugh; Alan G Barbour
Journal:  Clin Vaccine Immunol       Date:  2014-04-02

7.  Five-Antigen Fluorescent Bead-Based Assay for Diagnosis of Lyme Disease.

Authors:  Monica E Embers; Nicole R Hasenkampf; Mary B Barnes; Elizabeth S Didier; Mario T Philipp; Amanda C Tardo
Journal:  Clin Vaccine Immunol       Date:  2016-04-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.